Allogeneic hematopoietic cell transplantation using fludarabine plus myeloablative busulfan and melphalan confers promising survival in high-risk hematopoietic neoplasms: a single-center retrospective analysis.
Hematology
; 26(1): 186-198, 2021 Dec.
Article
in En
| MEDLINE
| ID: mdl-33594942
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antineoplastic Combined Chemotherapy Protocols
/
Hematopoietic Stem Cell Transplantation
/
Hematologic Neoplasms
/
Transplantation Conditioning
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Observational_studies
Aspects:
Patient_preference
Limits:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Hematology
Journal subject:
HEMATOLOGIA
Year:
2021
Document type:
Article
Affiliation country: